Q3 2026 · Nov 13, 2026
Small sales, bigger loss, costs getting cut
Its new heart drug is selling, but the loss grew to $25.8M. Cost cuts should make cash last into late 2028.
Read the report (Milestone Q3 2026)
Milestone (MIST): the news, the earnings reports and the groups that trade it. Bet it goes up or down on BagBot.
A call wins if Milestone finishes above your strike by expiry; a put, below. BagBot handles the rest.
Its new heart drug is selling, but the loss grew to $25.8M. Cost cuts should make cash last into late 2028.
Q3 2026: Small sales, bigger loss, costs getting cut. Its new heart drug is selling, but the loss grew to $25.8M. Cost cuts should make cash last into late 2028.
On BagBot you pick up or down and choose how much to put in. BagBot buys an options contract for it: a call if you think MIST goes up, a put if you think it goes down. You can lose everything you put in, and you can start on practice money.
Powered by BagBot